Allmade Co., Ltd. (CEO Oh Taek-gyu), an in vitro diagnostic medical device startup, has been selected as a "2025 Incheon City Promising Small and Medium-sized Enterprise." This designation ensures Allmade maintains its status as an Incheon City Excellent Enterprise for five years, through 2030.
The Incheon City Excellent Company Certification System, implemented since 1999, identifies and fosters small and medium-sized enterprises (SMEs) with outstanding technological prowess and growth potential within the region. The system certifies promising SMEs, visionary companies, and mid-sized growth ladder companies. Certified Excellent Companies receive various benefits, including interest rate differential support from the Management Stabilization Fund and additional points for various support programs hosted by Incheon City.
Allmade is developing a high-sensitivity in vitro diagnostic technology based on quantum dot luminescence signals, aiming to build a next-generation diagnostic platform capable of both speed and precision. Recognizing this technological prowess, Allmade was selected for support under the Incheon Metropolitan City and Incheon Technopark (ITP)'s "Incheon Rising Star 5th Generation" program. The company has also been selected for numerous government and local government support projects, including those supported by the Ministry of SMEs and Startups, the Ministry of Education, and the Incheon Center for Creative Economy and Innovation.
Oh Taek-gyu, CEO of Allmade, said, “Quantum dot-based in vitro diagnostics is an innovative technology with high precision, excellent photostability, and the convenience of multiple diagnosis and on-site diagnosis.” He added, “Next year, we will focus on advancing our technology and business to grow into a global bio-diagnostic company representing Incheon, and also contribute to regional development and job creation.”
- See more related articles
You must be logged in to post a comment.